World's Best Scientists 2026 revealed!
Yasuo Ohashi

Yasuo Ohashi

D-Index & Metrics

Medicine

D-Index
106
Citations
55793
World Ranking
6399
National Ranking
145

Overview

Yasuo Ohashi is affiliated with Chuo University in Japan and has contributed extensively to the field of Medicine, with a particular focus on oncology and cancer research. Their work spans multiple subfields including Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine.

The main topics of Yasuo Ohashi's research include:

  • Breast Cancer Treatment Studies
  • Cancer Treatment and Pharmacology
  • HER2/EGFR in Cancer Research
  • Advanced Breast Cancer Therapies
  • Breast Lesions and Carcinomas
  • Venous Thromboembolism Diagnosis and Management
  • Gastric Cancer Management and Outcomes

A number of recent papers illustrate the scope of their research contributions. These include:

  • "Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials," published in 2021 in The Lancet Oncology
  • "Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials," published in 2023 in The Lancet
  • "Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients," published in 2020 in Journal of Clinical Oncology
  • "Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes," published in 2020 in Kidney International
  • "Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry," published in 2020 in Japanese Journal of Clinical Oncology

Yasuo Ohashi frequently publishes in prominent journals such as:

  • Japanese Journal of Clinical Oncology
  • Journal of Clinical Oncology
  • Cancer Research
  • Breast Cancer Research and Treatment
  • The Lancet Oncology

The list of frequent co-authors includes:

  • Hirofumi Mukai
  • Yukari Uemura
  • Hideo Kunitoh
  • Norikazu Masuda
  • Shozo Ohsumi

Overall, Yasuo Ohashi's research activities demonstrate a sustained focus on cancer treatment modalities, particularly breast cancer therapies and their related clinical outcomes. Their involvement with clinical trial data and meta-analyses indicates engagement with evidence-based approaches to oncology and related complications such as venous thromboembolism in cancer patients.

Best Publications

  • Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women: A Meta-analysis

    Satoru Kodama;Kazumi Saito;Shiro Tanaka;Miho Maki

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.

    Norikazu Masuda;Soo-Jung Lee;Shoichiro Ohtani;Young-Hyuck Im

  • Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

    Mitsuru Sasako;Shinichi Sakuramoto;Hitoshi Katai;Taira Kinoshita

  • Primary prevention of cardiovascular disease with pravastatin in Japan (mega study) : A prospective randomised controlled trial

    Haruo Nakamura;Kikuo Arakawa;Hiroshige Itakura;Akira Kitabatake

  • Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

    Tadatoshi Takayama;Teruaki Sekine;Masatoshi Makuuchi;Susumu Yamasaki

  • Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

    Katsuhiko Uesaka;Narikazu Boku;Akira Fukutomi;Yukiyasu Okamura

  • Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis

    Gastric (Global Advanced);Xavier Paoletti;Koji Oba

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

    Y Ohe;Y Ohashi;K Kubota;T Tamura

  • EFFECT OF AEROBIC EXERCISE TRAINING ON SERUM LEVELS OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL: A META-ANALYSIS

    Satoru Kodama;Shiro Tanaka;Kazumi Saito;Miao Shu

  • Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

    J. Bergh;K. Pritchard;K. Albain;S. Anderson

  • Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

    Hideki Ueno;Tatsuya Ioka;Masafumi Ikeda;Shinichi Ohkawa

  • Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial

    Norio Kohno;Kenjiro Aogi;Hironobu Minami;Seigo Nakamura

  • Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.

    Yukito Shinohara;Yasuo Katayama;Shinichiro Uchiyama;Takenori Yamaguchi

  • Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial

    Noriaki Ohuchi;Akihiko Suzuki;Tomotaka Sobue;Masaaki Kawai

  • Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project

    Takeshi Sano;Daniel G. Coit;Hyung Ho Kim;Franco Roviello

  • Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction.

    Fumio Gotoh;Hideo Tohgi;Shunsaku Hirai;Akiro Terashi

  • Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.

    Kazumoto Iijima;Mayumi Sako;Kandai Nozu;Rintaro Mori

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

Frequent Co-Authors

Hirohito Sone
Hirohito Sone Niigata University
Nobuhiro Yamada
Nobuhiro Yamada University of Tsukuba
Hiroji Iwata
Hiroji Iwata Aichi Cancer Center
Yasuo Akanuma
Yasuo Akanuma University of Tokyo
Satoshi Morita
Satoshi Morita Kyoto University
Masunori Matsuzaki
Masunori Matsuzaki Yamaguchi University
Takuji Okusaka
Takuji Okusaka National Cancer Centre
Toshio Ogihara
Toshio Ogihara Osaka University
Hiromi Rakugi
Hiromi Rakugi Osaka University
Shun Ishibashi
Shun Ishibashi Jichi Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in complementing or expanding your future in medicine, there are a variety of online degrees and career-focused programs available in health and healthcare management. For nurses aiming to advance their clinical skills and expand their scope of practice, rn to np programs provide a flexible bridge from registered nurse to nurse practitioner, often blending online coursework with practical experience.

Nutrition is a growing field for those who want to support health and well-being beyond clinical care. Earning an online bs in nutrition can open doors to careers in preventative health, food policy, and wellness coaching.

For students interested in management and administrative roles, cahme-accredited online mha programs offer a pathway to leadership positions in hospitals, clinics, and health systems. These programs meet high accreditation standards and are designed for flexibility.

Finally, nurses wishing to complete their Bachelor of Science in Nursing without onsite clinical requirements can explore rn to bsn without clinicals options, which are ideal for working professionals needing convenience and speed.

Best Scientists Citing Yasuo Ohashi

Trending Scientists

Recently Published Articles